hero image
Professor Emma Robinson - University of Bristol. Bristol, , GB

Professor Emma Robinson Professor Emma Robinson

Professor of Psychopharmacology | University of Bristol

Bristol, UNITED KINGDOM

Improving the effectiveness of antidepressant drugs and the treatment of depression

Areas of Expertise (7)

Emotion

Neuroscience

Mental Health

Antidepressants

Depression

Mood

Pharmacology

Biography

Professor Emma Robinson is based in the School of Physiology, Pharmacology and Neuroscience. She studies the mechanisms of action of antidepressant drugs with a particular interest in identifying new ways to treat mood disorders. She is currently working with a new class of rapid-acting antidepressants which can provide a more effective and sustained treatment. Professor Robinson uses novel behavioural methods to examine issues such as the interaction between biological and psychological mechanisms and how these contribute to antidepressant treatment, anhedonia (a common symptom of depression where patients have a loss of interest in engaging in previously rewarding activities), and the treatment potential of drugs such as ketamine, psilocybin and other psychedelic drugs. Her work on studying emotional behaviour in non-human species has also led to studies with a focus on laboratory animal welfare.

These studies have now expanded to new research programmes designed to understand the mechanisms which underlie rapid acting antidepressants effects, including a programme with Boehringer Ingelheim which arose from an Innocentive Challenge competition. Professor Robinson is an Independent Expert Advisor on the Wellcome Trust Mental Health Strategy and has written a British Medical Association textbook of the year, 'Neuroanatomy and Neuroscience at a Glance'. She is actively involved in public engagement, organising the biennial Bristol Neuroscience Festival. She was also awarded the British Neuroscience Association’s Public Engagement in Neuroscience Award.

Media

Publications:

Documents:

Photos:

Videos:

BNF 2 LMUK Bristol Neuroscience Festival | 10th Anniversary

Audio:

Social

Accomplishments (3)

Independent Expert Advisor, Wellcome Trust Mental Health Strategy

2020

Best of Bristol Lecturer

2019

Invited ECNP Plenary Speaker, Vienna

2020

Education (2)

University of Bristol: Ph.D., Pharmacology 1999

University of Bristol: B.Sc., Pharmacology 1995

Media Appearances (3)

Stress in early life may up depression risk, says study

The Indian Express  online

2019-05-10

“This study supports a wider body of literature which suggests that depression may develop from an interesting yet complex interaction between biological and psychological processes,” said Emma Robinson, professor at University of Bristol.

view more

How do you study stress in an animal?

Understanding Animal Research  online

2019-05-02

It is known to play an important role in many diseases suggesting that both acute and chronic stress can cause illness leading to changes in behaviour and physiology. In this context, Professor Emma Robinson from the University of Bristol is interested in stress as a major risk factor in depression. Her works involved about 90% animal work and 10% human research.

view more

Is your statin affecting your memory? Study finds some commonly prescribed brands can impair brain function

Daily Mail  online

2013-09-25

Bristol University researchers say their study tallies with reports of statin patients feeling ‘fuzzy-headed’ and ‘befuddled’. The team also said it was ‘highly likely’ other statins affected memory loss.

view more

Articles (5)

Comparison of acute treatment with delayed-onset versus rapid-acting antidepressants on effort-related choice behaviour

Psychopharmacology

2020 Rationale Reward-related impairments are common in major depressive disorder (MDD) and may contribute to the loss of interest in pleasurable activities. A novel approach to studying reward-related decision-making are effort-based tasks; however, direct comparisons between delayed-onset and rapid-acting antidepressants (ADs) have not yet been carried out.

view more

Impulsivity is a heritable trait in rodents and associated with a novel quantitative trait locus on chromosome 1

Scientific Reports

2020 Impulsivity describes the tendency to act prematurely without appropriate foresight and is symptomatic of a number of neuropsychiatric disorders. Although a number of genes for impulsivity have been identified, no study to date has carried out an unbiased, genome-wide approach to identify genetic markers associated with impulsivity in experimental animals.

view more

Investigating hormone-induced changes in affective state using the affective bias test in male and female rats

Psychoneuroendocrinology

2020 Recent clinical and pre-clinical research suggests that affective biases may play an important role in the development and perpetuation of mood disorders. Studies in animals have also revealed that similar neuropsychological processes can be measured in non-human species using behavioural assays designed to measure biases in learning and memory or decision-making.

view more

Comparison of conventional and rapid-acting antidepressants in a rodent probabilistic reversal learning task

Brain and Neuroscience Advances

2020 Deficits in reward processing are a central feature of major depressive disorder with patients exhibiting decreased reward learning and altered feedback sensitivity in probabilistic reversal learning tasks. Methods to quantify probabilistic learning in both rodents and humans have been developed, providing translational paradigms for depression research.

view more

Translating a rodent measure of negative bias into humans: the impact of induced anxiety and unmedicated mood and anxiety disorders

Psychological Medicine

2020 Mood and anxiety disorders are ubiquitous but current treatment options are ineffective for many sufferers. Moreover, a number of promising pre-clinical interventions have failed to translate into clinical efficacy in humans. Improved treatments are unlikely without better animal–human translational pipelines.

view more